Brind.
  1. MarketBeat used its screener tool to monitor financial health on June 10, 2026.
  2. Johnson & Johnson, UnitedHealth Group, and Intuitive Surgical are noted as major players in the high-volume U.S. healthcare sector.
  3. Intuitive Surgical is developing and marketing its da Vinci product line and Ion Endoluminal system in the US market.

FDA cleared the first da Vinci system for Intuitive Surgical on August 21, 2025.

4 reports, 1 independent Updated Aug 15
Gone quiet
Reports
4
Developments
1
Repetition
75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

FDA cleared the first da Vinci system for Intuitive Surgical on August 21, 2025.

Who's involved

What this event is mainly about
FDAIntuitive Surgical

Keep exploring

Part of

Intuitive Surgical is developing and marketing its da Vinci product line and Ion Endoluminal system in the US market. All 1 developments

Within MarketBeat used its screener tool to monitor financial health on June 10, 2026.

The entities involved

Coverage

Newest first; wire copies grouped
  • StockStory2 Reasons to Like ISRG (and 1 Not So Much) Over the last six months, Intuitive Surgical’s shares have sunk to $480, producing a disappointing 18.9% loss - a stark contrast to the S&P 500’s 6.4% gain.
  • StockStoryQ2 Earnings Highs And Lows: Intuitive Surgical (NASDAQ:ISRG) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks As the craze of earnings season draws to a close, here’s a look bac
2 more outlets ran the same wire story